-

PACS Group Under Federal Investigation: Investors Urged to Contact Award-Winning Firm, Gibbs Law Group LLP

OAKLAND, Calif.--(BUSINESS WIRE)--Shares of PACS Group, Inc. (“PACS Group”) plunged over 42% in intraday trading on Wednesday, November 6, 2024, after it disclosed a federal investigation into its reimbursement and referral practices. Previously, it dropped 27% on Monday, November 4, 2024, following a Hindenburg Research report accusing the company of “systematically scamming taxpayer-funded healthcare programs” and operating a scheme to give the illusion of growth and profitability. Gibbs Law Group is investigating a potential PACS Group (NYSE:PACS) Securities Class Action Lawsuit on behalf of shareholders who lost money in PACS Group, Inc.

What Should PACS Group Investors Do?

If you invested in PACS Group, visit our website, or call us toll-free at (888) 410-2925 to get more information and discuss how you may be able to recover your losses. Our investigation concerns whether PACS Group has violated federal securities laws by providing false or misleading statements to investors.

What is the PACS Group Lawsuit Investigation About?

On November 6, 2024, PACS Group disclosed that it would delay the release of its 2024 Q3 earnings results amidst a government investigation into its reimbursement and referral practices.

This announcement followed a Hindenburg Research report published on November 4, 2024, alleging that PACS Group employed a “turnaround” strategy of “transforming poorly performing skilled nursing facilities into cash spigots” by “systematically scamming taxpayer-funded healthcare programs.” The report further claims that PACS Group tried to return to COVID-level profitability “by billing thousands of unnecessary respiratory and sensory integration therapies to Medicare Part B regardless of clinical need or outcomes.” Hindenburg Research estimates that this scheme “drove more than 100% of PACS’ operating and net income from 2020 – 2023, enabling PACS to IPO in early 2024 with the illusion of legitimate growth and profitability.”

Following this news, shares of PACS Group plummeted over 42% in intraday trading on November 6, 2024, causing significant harm to investors.

About Gibbs Law Group

Gibbs Law Group represents investors throughout the country in securities litigation to correct abusive corporate governance practices, breaches of fiduciary duty, and proxy violations. The firm has recovered over a billion dollars for its clients against some of the world’s largest corporations, and our attorneys have received numerous honors for their work, including “Best Lawyers in America,” “Top Plaintiff Lawyers in California,” “California Lawyer Attorney of the Year,” “Class Action Practice Group of the Year,” “Consumer Protection MVP,” and “Top Women Lawyers in California.”

This press release may constitute Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

CATHERINE CONROY
PHONE: 510.350.9705
EMAIL: CRC@CLASSLAWGROUP.COM

Gibbs Law Group LLP

NYSE:PACS

Release Summary
Gibbs Law Group is investigating potential legal claims on behalf of PACS Group investors.
Release Versions
$Cashtags
Hashtags

Contacts

CATHERINE CONROY
PHONE: 510.350.9705
EMAIL: CRC@CLASSLAWGROUP.COM

More News From Gibbs Law Group LLP

Top Plaintiff Firms Join Forces for Law Students: The Mason Gibbs Plaintiffs' Pathway Fellowship

OAKLAND, Calif.--(BUSINESS WIRE)--The Mason Gibbs Plaintiffs’ Pathway Fellowship has now launched, offering exceptional 1L law students the opportunity to spend their summer at leading plaintiff firms across the country holding corporations accountable for misconduct and protecting the rights of ordinary individuals. Students will have the opportunity to be placed in the summer of 2026 at Gibbs Mura LLP, in Oakland, CA; Singleton Schreiber, with 17 offices in different cities; Koskoff Koskoff &...

Ardent Health, Inc. (ARDT) Under Investigation After Shares Plummet Over 33%

OAKLAND, Calif.--(BUSINESS WIRE)--Gibbs Mura is investigating a potential securities class action lawsuit on behalf of Ardent Health, Inc. (NYSE: ARDT) investors....

Lawsuit Filed Against Stride, Inc. (LRN) After Shares Plummet Over 51%

OAKLAND, Calif.--(BUSINESS WIRE)--Gibbs Mura announces that a class action lawsuit has been filed against Stride, Inc. (“Stride”) on behalf of investors who purchased or acquired Stride securities between October 22, 2024 and October 28, 2025. Shares of Stride, Inc. plummeted over 51% in intraday trading on October 29, 2025, after the company reported a weak 2026 financial forecast, citing platform upgrades that resulted in a “poor customer experience” and a large decrease in enrollment numbers...
Back to Newsroom